Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study

Schulman, S; Ritchie, B; Nahirniak, S; Gross, PL; Carrier, M; Majeed, A; Hwang, HG; Zondag, M

Schulman, S (reprint author), HHS Gen Hosp, Thrombosis Serv, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.

THROMBOSIS RESEARCH, 2017; 152 ( ): 44

Abstract

The reversal of dabigatran-associated major bleeding can now be achieved with the antidote idarucizumab. We evaluated activated prothrombin complex co......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索